ANGOAngiodynamic Inc
ANGO
Angiodynamic Inc1,048
Mkt Cap
$455.75MVolume
49,648.0052W High
$13.9952W Low
$8.36PE Ratio
-14.52ANGO Fundamentals
Price
$10.93Prev Close
$11.03Open
$10.9750D MA
$10.77Beta
1.09Avg. Volume
506,407.72EPS (Annual)
-$0.8321P/B
2.65Rev/Employee
$433,330.37$364.75
AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer
AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient...
Business Wire·2d ago
Wall Street Analysts Think AngioDynamics (ANGO) Could Surge 64.23%: Read This Before Placing a Bet
The mean of analysts' price targets for AngioDynamics (ANGO) points to a 64.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·9d ago
136,333 Shares in AngioDynamics, Inc. $ANGO Bought by D.A. Davidson & CO.
D.A. Davidson & CO. acquired a new position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·12d ago
AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Up 18.7% in April
AngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totaling 2,161,213...
MarketBeat·15d ago
Weber Capital Management LLC ADV Invests $17.98 Million in AngioDynamics, Inc. $ANGO
Weber Capital Management LLC ADV acquired a new position in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,400,149 shares of the medical instruments su...
MarketBeat·18d ago
FY2026 EPS Estimates for AngioDynamics Increased by Analyst
AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Investment analysts at Zacks Research raised their FY2026 earnings estimates for AngioDynamics in a research report issued on Thursday, April 23rd...
MarketBeat·18d ago
AngioDynamics, Inc. (NASDAQ:ANGO) Given Consensus Recommendation of "Moderate Buy" by Analysts
AngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the six analysts that are covering the company, MarketBeat.com reports. One...
MarketBeat·22d ago
Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 65.75%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 65.8% in AngioDynamics (ANGO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·25d ago
AngioDynamics CEO Touts Debt-Free Turnaround, Auryon Share Gains, NanoKnife Launch at Needham Conf
AngioDynamics (NASDAQ:ANGO) CEO Jim Clemmer used a presentation at Needham & Company's 25th Annual Needham Healthcare Conference to outline the company's multi-year transformation, highlight growth...
MarketBeat·1mo ago
AngioDynamics (ANGO) Loses 5.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for AngioDynamics (ANGO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Zacks·1mo ago
<
1
2
...
>